Search Results
Dr. Klotz - What's New in Active Surveillance for Prostate Cancer in 2021
What's New in Active Surveillance for Prostate Cancer
Active Surveillance in 2022 | Laurence Klotz, MD | PCRI
3+4=7 #ProstateCancer | Active Surveillance vs. Focal Therapy | #MarkScholzMD #AlexScholz #PCRI
49: Active Surveillance for Low-Risk Prostate Cancer with Laurence Klotz, M.D.
Active Surveillance 2022: Who Qualifies, Who Does Not and How Should it be Monitored
Active Surveillance 2021 - From Bench to Bedside
Anxiety, Mental Health & Active Surveillance | Experts Laurence Klotz, MD & Mark Moyad, MD Discuss
Active Surveillance in Favorable Intermediate-Risk Prostate Cancer
Active Surveillance with Dr. Laurence Klotz - ZERO Prostate Cancer Summit 2022
Active Surveillance: From Bench to Bedside - Dr. Larry Klotz
Active Surveillance in 2021 Part 2: Imaging and Biomarkers
